What’s Holding Up New Omicron Vaccines?
Vaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one
health
Scientists Square Off Over Covid, Wuhan, and Peter Daszak
A group of academics claim the president of EcoHealth Alliance has misled the public amid Covid origins investigations.
Gain-of-Function Research: All in the Eye of the Beholder
Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
Fauci on COVID Drugs, Vaccines and Getting Back to Normal
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens
There Are Few Good COVID Antivirals, but That Could Be Changing
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
COVID-19 long haulers
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.